Evidence map›Paper›PMID 41325310›Full record

ArticlePloS one2025

Annual U.S. healthcare expenditures attributable to cigar smoking between 2001 and 2018, overall and by payer.

Xin Xu, Ghada Homsi, Sherry T Liu, Jennifer M Gaber, Naa A Inyang, Brian L Rostron, Caryn F Nagler, James Nonnemaker

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xin XuCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.
Ghada HomsiRTI International, Research Triangle Park, North Carolina, United States of America.
Sherry T LiuCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.
Jennifer M GaberRTI International, Research Triangle Park, North Carolina, United States of America.ORCID https://orcid.org/0000-0002-1467-0115
Naa A InyangCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.
Brian L RostronCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.
Caryn F NaglerCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.
James NonnemakerRTI International, Research Triangle Park, North Carolina, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2022, 3.7% of U.S. adults currently smoked cigars. This study assesses cigar-smoking-attributable fractions in U.S. healthcare expenditures and associated annual healthcare expenditures overall and by payer, including publicly funded healthcare programs.

methodsData were obtained from the 2000, 2005, 2010, and 2015-2017 National Health Interview Survey linked with corresponding panels from the Medical Expenditure Panel Survey data through 2018. The final sample (n = 53,733) was restricted to adults aged 25 + . Estimates from four-part models and data from the Personal Health Care component of the 2001-2018 National Health Expenditures Accounts were combined to estimate fractions of and annual healthcare expenditures attributable to cigar smoking. All models controlled for sociodemographic characteristics and health-related behaviors.

resultsDuring 2001-2018, an estimated 1.8% (95% CI = 0.9%-3.4%) or $29.7 billion annually of U.S. healthcare expenditures could be attributed to cigar smoking. Most of this was funded by other third-party health insurance programs, a mix of private and public payers (e.g., Department of Veterans Affairs).

conclusionsCigar smoking creates a preventable financial burden on the U.S. healthcare system. Health consequences associated with cigar smoking may remain after successful quitting. The findings underscore the importance of preventing initiation of cigar smoking and providing evidence-based cessation methods to reduce the health and economic burden of cigar smoking.

Indexed as

Health ExpendituresSmokingAdultAgedFemaleHumansInsurance, HealthMaleMiddle AgedUnited States

Identifiers

PMID41325310
PMCPMC12668525

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.